Finance

Lists
Why is BRKR down 3,08%?
Dive Deeper
BRKR:NASDAQ
Bruker Corp
54,80 USD
-3,08%
(-1,74) 1D
54,80 USD
0,00% (0,00)
After hours
Closed: 16-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRKR...
Open
56,45 USD
High
57,18 USD
Low
54,26 USD
Mkt. cap
8,35 млд
Avg. vol.
2,29 млн
Volume
1,67 млн
Dividend
0,36%
Quarterly dividend
0,05 USD
Ex-dividend date
2026-ж., 21-сен.
52-wk high
66,98 USD
52-wk low
32,38 USD
EPS
-0,70 USD
Beta
1,22
Shares outstanding
152,36 млн
No. of employees
11 миң
Open
56,45 USD
High
57,18 USD
Low
54,26 USD
Mkt. cap
8,35 млд
Avg. vol.
2,29 млн
Volume
1,67 млн
Dividend
0,36%
Quarterly dividend
0,05 USD
Ex-dividend date
2026-ж., 21-сен.
52-wk high
66,98 USD
52-wk low
32,38 USD
EPS
-0,70 USD
Beta
1,22
Shares outstanding
152,36 млн
No. of employees
11 миң
News stories
From web sources and news partners
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOFrank Laukien
Employees11,1 миң
Founded1960
HeadquartersБиллерика, Массачусетс, Америка Кошмо Штаттары
SectorHealth care
Websitebruker.com
Analyst ratings
Based on 10 analysts giving stock ratings to BRKR in the past 3 months
Buy
Buy
5
Hold
4
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BRKR in the last 3 months.
Highest
Current 54,80 USD
80,00 USD (+45,99%)
Average
61,33 USD (+11,92%)
Lowest
50,00 USD (-8,76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Casey Woodring
J.P. Morgan
Hold
Downgraded
60,00 USD
+9,5%
10/14/2026
Daniel Brennan
TD Cowen
Hold
Maintained
62,00 USD
+13,1%
10/13/2026
Luke Sergott
Barclays
Buy
Maintained
70,00 USD
+27,7%
10/07/2026
Unknown Analyst
Goldman Sachs
Sell
Maintained
50,00 USD
-8,8%
10/05/2026
Evie Koslosky
Goldman Sachs
Sell
Maintained
50,00 USD
-8,8%
10/05/2026
Subbu Nambi
Guggenheim
Buy
Maintained
72,00 USD
+31,4%
10/01/2026
Puneet Souda
Leerink Partners
Buy
Maintained
80,00 USD
+46%
09/29/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/05/2026
Evan Stampler
Wells Fargo
Buy
Maintained
55,00 USD
+0,4%
08/05/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
55,00 USD
+0,4%
08/05/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
50,00 USD
-8,8%
08/05/2026
Patrick B Donnelly
Citi
Hold
Maintained
53,00 USD
-3,3%
08/05/2026
Kyle Boucher
TD Cowen
Hold
Maintained
60,00 USD
+9,5%
08/04/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Dan Leonard
RBC Capital
Hold
Reiterated
45,00 USD
-17,9%
05/07/2026
Tycho Peterson
Jefferies
Buy
Maintained
50,00 USD
-8,8%
02/12/2026
Last report
2026-ж., 4-авг.
Fiscal period
Q2 2026
0,49 USD / 0,38 USD
+27,49%beat
Revenue / Est. (USD)
838,50 млн / 853,57 млн
-1,77%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
860,50 млн
977,20 млн
823,40 млн
838,50 млн
Cost of goods sold
446,30 млн
510,40 млн
428,20 млн
421,40 млн
Cost of revenue
446,30 млн
510,40 млн
428,20 млн
421,40 млн
Research and development expenses
98,30 млн
99,60 млн
101,30 млн
94,30 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
242,50 млн
244,20 млн
242,10 млн
238,90 млн
Operating expense
302,70 млн
402,50 млн
344,30 млн
334,30 млн
Total operating expenses
749,00 млн
912,90 млн
772,50 млн
755,70 млн
Operating income
111,50 млн
64,30 млн
50,90 млн
82,80 млн
Other non operating income
9,30 млн
-5,70 млн
3,00 млн
4,00 млн
EBT including unusual items
-72,60 млн
67,00 млн
18,20 млн
-36,70 млн
EBT excluding unusual items
106,60 млн
54,20 млн
47,30 млн
87,90 млн
Income tax expense
-14,10 млн
37,80 млн
2,50 млн
14,20 млн
Effective tax rate
19,42%
56,42%
13,74%
-38,69%
Other operating expenses
-38,10 млн
58,70 млн
800,00 миң
1,10 млн
Net income
-59,60 млн
26,00 млн
14,40 млн
-52,00 млн
Net profit margin
-6,93%
2,66%
1,75%
-6,20%
Earnings per share
0,45
0,59
0,31
0,49
Interest and investment income
4,40 млн
4,60 млн
4,90 млн
11,30 млн
Interest expense
-20,30 млн
-11,20 млн
-12,20 млн
-17,80 млн
Net interest expenses
-15,90 млн
-6,60 млн
-7,30 млн
-6,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
167,20 млн
122,40 млн
109,20 млн
140,80 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору